How to Fairly Allocate Scarce COVID-19 Therapies

Document Type

Article

Year

2022

Abstract

Vaccines are no longer our only medical intervention for preventing severe COVID-19. Over the past few months, we have seen the arrival and wider availability of treatments such as monoclonal antibodies (mAbs), and more recently, of novel oral antiviral drugs like Paxlovid and molnupiravir. The recent Delta and Omicron surges have made these therapies scarce.

Share

COinS